Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion

  • Am J Hum Genet. 2005 Jun;76(6):1081-6. doi: 10.1086/430843.
Orly Elpeleg  1 ,  Chaya Miller ,  Eli Hershkovitz ,  Maria Bitner-Glindzicz ,  Gili Bondi-Rubinstein ,  Shamima Rahman ,  Alistair Pagnamenta ,  Sharon Eshhar ,  Ann Saada
Affiliations
  • 1. Metabolic Disease Unit, Shaare-Zedek Medical Center, Jerusalem, Israel. [email protected].
Abstract

The mitochondrial DNA (mtDNA) depletion syndrome is a quantitative defect of mtDNA resulting from dysfunction of one of several nuclear-encoded factors responsible for maintenance of mitochondrial deoxyribonucleoside triphosphate (dNTP) pools or replication of mtDNA. Markedly decreased succinyl-CoA synthetase activity due to a deleterious mutation in SUCLA2, the gene encoding the beta subunit of the ADP-forming succinyl-CoA synthetase Ligase, was found in muscle mitochondria of patients with encephalomyopathy and mtDNA depletion. Succinyl-CoA synthetase is invariably in a complex with mitochondrial nucleotide diphosphate kinase; hence, we propose that a defect in the last step of mitochondrial dNTP salvage is a novel cause of the mtDNA depletion syndrome.